BAT7104 Injection in Patients With Advanced Malignant Tumors.
Status:
Recruiting
Trial end date:
2024-01-20
Target enrollment:
Participant gender:
Summary
A multi-center, open phase Ia/Ib clinical study to evaluate the safety, tolerance,
pharmacokinetics and preliminary clinical efficacy of BAT7104 injection in patients with
advanced malignant tumors.